EuroIntervention PCRonline - Connecting with the community

Jacques Berland

11 articles

Safety and efficacy of a bioabsorbable polymer-coated, everolimus-eluting coronary stent in patients with diabetes: the EVOLVE II diabetes substudy

EuroIntervention 2017;12:1987-1994 published online November 2016

Published in Volume 12 Number 16, March 2017

STENTYS Self-Apposing® sirolimus-eluting stent in ST-segment elevation myocardial infarction: results from the randomised APPOSITION IV trial

EuroIntervention 2016;11:e1267-e1274 published online e-edition February 2016

Published in Volume 11 Number 11, February 2016

DANUBIO - a new drug-eluting balloon for the treatment of side branches in bifurcation lesions: six-month angiographic follow-up results of the DEBSIDE trial

EuroIntervention 2015;11:868-876

Published in Volume 11 Number 8, December 2015

The Nile CroCo and Nile PAX stents

EuroIntervention 2015;11:V149-V150

Published in Volume 11 Supplement V, May 2015

Dedicated stents for distal left main stenting

EuroIntervention 2015;11:V129-V134

Published in Volume 11 Supplement V, May 2015

Everolimus-eluting stent for the treatment of bare metal in-stent restenosis: clinical and angiographic outcomes at nine-month follow-up of XERES (Xience Evaluation in bare metal stent REStenosis) trial

EuroIntervention 2014;10:700-708 published online ahead of print December 2013

Published in Volume 10 Number 6, October 2014

Procedural and early clinical outcomes of patients with de novo coronary bifurcation lesions treated with the novel Nile PAX dedicated bifurcation polymer-free paclitaxel coated stents: results from the prospective, multicentre, non-randomised BIPAX clinical trial

EuroIntervention 2012;7:1301-1309

Published in Volume 7 Number 11, March 2012

Complex coronary bifurcation lesions treated with the novel polymer-free dedicated bifurcation paclitaxel-eluting stent (Nile pax): clinical and angiographic clinical results of the prospective, multicentre bipax clinical trial

Published in Volume 7 Supplement M, May 2011

e-BioMatrix PMS Registry - A post market surveillance registry for the BioMatrix™ drug-eluting stent

Published in Volume 7 Supplement M, May 2011

Coronary bifurcation lesions treated with the novel Nile PAX polymer-free dedicated bifurcation paclitaxel-eluting stent. Preliminary results from the prospective, multicenter BIPAX clinical trial

Published in Volume 6 Supplement H, May 2010

Differentiated analysis of an everolimus-eluting stent and a paclitaxel-eluting stent among higher risk subgroups for restenosis: results from the SPIRIT II trial

EuroIntervention 2008;3:566-573 - DOI10.4244/EIJV3I5A102

Published in Volume 3 Number 5, March 2008